跨导管三管瘤整形脱位的并发症管理
Vasileios Exarchos1, Andi Rroku1, Mario Kasner1
1Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, Campus Benjamin Franklin, Berlin, Germany; Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
JACC. Case reports
|October 25, 2025
概括
透导管三管干预措施对严重的二次三管吐 (TR) 有希望. 这一案例系列强调了需要仔细选择患者和适应性策略,以便在复杂心力衰竭患者中获得最佳结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 严重的二次三回 (TR) 显著影响心力衰竭症状和死亡率,特别是在老年患者中.
- 透导管三门干预措施为高风险患者提供了替代方案.
研究的目的:
- 报告严重功能性TR的透导管干预措施.
- 讨论这些新疗法的挑战和结果.
主要方法:
- 两名患有大量TR的患者通过心脏带系统进行了透导管取消术.
- 随后的治疗涉及由于装置脱而发生的跨导管三门更换.
主要成果:
- 最初的废除整形改善了TR的严重程度和症状.
- 装置脱位需要更换门,导致显著的临床改善.
结论:
- 对于严重的功能性TR而言,透导管疗法既具有潜力,也面临挑战.
- 谨慎的患者选择,监测和适应策略对于优化结果至关重要.
相关概念视频
Mitral Stenosis III: Medical Management
245
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
245
Aortic Regurgitation III: Medical Management
392
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
392
Mitral Valve Prolapse III: Nursing Management
283
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
283
Mitral Regurgitation III: Medical Management
274
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
274
Pericarditis III: Medical Management
307
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
307
Mitral Valve Prolapse II: Assessment and Management
411
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
411


